Facilitating Pulmonary Arterial Hypertension Medication Adherence: Patient-centered Management

Advances in Pulmonary Hypertension

¹ 

关键词: Cardiology;    Psychosocial Issues;    Lifestyle Issues;    Nursing;    Pharmacy;    Respiratory Therapy;    Social Work;    WHO Group 1- Pulmonary Arterial Hypertension;    PH Medications;    Pulmonary Function Tests;    Surgical Interventions;    symptoms;    Neonatal;    PPHN;    Oral therapy;    Phosphodiesterase Inhibitors (PDE-5 Inhibitors);    Medication Adherence;    Diuretics;    Spirometry;    Preserved ejection fraction;    endothelial dysfunction;    dyspnea;    Pregnancy;    patient-reported outcomes;    Drug development;    Education;    CEU;    Medicare;    Classification;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

Limited data suggest liver transplantation (LT) is considered high risk (35% post-transplant hospitalization mortality when untreated, pre-LT MPAP exceeds moderate levels; ie, >35 mm Hg).8 Based on a 10-year prospective screening program from the Mayo Clinic, estimates are that 5% of all LT candidates have some degree of POPH.9 Approximately 65% of all screened LT candidates with right ventricular systolic pressure >50 mm Hg by echo have POPH; 35% have high flow or excess volume states. Adverse prognosis of POPH is related to the severity of liver disease and reduced cardiac output.

【 授权许可】

All Rights reserved